Page 34 - Special Access Program News Today

In their latest bombshell report related to unidentified aerial phenomena released by the New York Times , the mainstream

“Sets the right tone, right standard, and right policy”: Optimi Health CEO, Bill Ciprick...

Company will host in-person and virtual tours for media, investors, and residents on May 27, 2022....

/PRNewswire/ - Today, LongTermGevity is pleased to announce that they have received a Dealers Licence from Health Canada that allows for the possession,...

Numinus Wellness Inc. (OTCPK:NUMIF) Q2 2022 Results Conference Call April 14, 2022 05:30 PM ET Company Participants Jamie Kokoska - VP, IR Payton Nyquvest - Founder and CEO John Fong - CFO...

"Having this approval, I feel like the luckiest person. I know a number of people with cancer who have died waiting for one," says patient Thomas Hartle.

01.04.2022 - MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval Company Advances IP Portfolio With New Patent Applications Covering Novel Molecule Families DENVER, March 31, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations ...

A new clinic in southwest Calgary is treating chronic pain and mental health struggles with ketamine injections among other holistic treatments and therapies.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

The products by Vancouver-based biotech company scheduled to hit the shelves at select Alberta locations in May